IP Library Granted Patent US 8,461,203
Granted Patent B2
US 8,461,203 · App. 13/182,324 · Granted Jun 11, 2013

Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,461,203
App. No.
13/182,324
Granted
Jun 11, 2013
Kind
B2
Abstract

Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.

Claims (16)

1. A method of rendering an aqueous medium resistant to microbial growth, said method comprising admixing a salt of gamma hydroxybutyrate with the aqueous medium, adjusting the concentration of the gamma-hydroxybutyrate salt in the aqueous medium to a final concentration of from about 310 to about 750 mg/ml, and adjusting the pH of the medium to a final pH of about 6 to about 9, so that the medium is chemically stable and resistant to microbial growth, wherein the medium would not need to contain a preservative.

2. The method of claim 1 , wherein said salt is sodium gamma-hydroxybutyrate.

3. The method of claim 1 , wherein said pH-adjusting agent is an organic acid.

4. The method of claim 3 , wherein said acid is selected from the group consisting of malic acid, citric acid, acetic acid, boric acid, lactic acid, hyrochloric acid, phosphoric acid, sulfuric acid, and nitric acid.

5. The method of claim 1 , wherein the concentration is from about 450 to about 600 mg/ml.

6. The method of claim 1 , wherein the concentration is about 500 mg/ml.

7. The method of claim 1 , wherein the components are admixed sequentially.

8. The method of claim 1 , wherein the components are admixed simultaneously.

9. A method of rendering an aqueous medium comprising a salt of gamma-hydroxybutyrate resistant to microbial growth, said method comprising adjusting the concentration of the gamma-hydroxybutyrate salt in the aqueous medium to a final concentration of from about 310 to about 750 mg/ml, and adjusting the pH of the medium to a final pH of about 6 to about 9, so that the medium is chemically stable and resistant to microbial growth, wherein the medium does not contain a preservative.

10. A method of rendering an aqueous medium comprising a salt of gamma-hydroxybutyrate resistant to microbial growth, said method comprising contacting a salt of gamma hydroxybutyrate with the aqueous medium, adjusting the concentration of the gamma-hydroxybutyrate salt in the aqueous medium to a final concentration of from about 310 to about 750 mg/ml, and adjusting the pH of the medium to a final pH of about 6 to about 9, so that the medium is chemically stable and resistant to microbial growth, wherein the medium does not contain a preservative.

11. The method of claim 9 or 10 , wherein the salt is sodium gamma-hydroxybutyrate.

12. The method of claim 9 or 10 , wherein said pH-adjusting agent is an organic acid.

13. The method of claim 12 , wherein said acid is selected from the group consisting of malic acid, citric acid, acetic acid, boric acid, lactic acid, hydrochloric acid, phosphoric acid, sulfuric acid, and nitric acid.

14. The method of claim 9 or 10 , wherein the concentration of the gamma-hydroxybutyrate salt is from about 450 to about 600 mg/ml.

15. The method of claim 9 or 10 , wherein the concentration of the gamma-hydroxybutyrate salt is about 500 mg/ml.

16. The method of claim 1 , wherein the medium does not contain a preservative.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded May 5, 2021
From: BANK OF AMERICA, N.A.
To: JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED; CELATOR PHARMACEUTICALS, INC.; CAVION, INC.
Reel/Frame 056150/0708 →
SECURITY AGREEMENT Recorded May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →
RELEASE OF SECURITY INTEREST Recorded Jul 9, 2015
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: EUSA PHARMA (USA), INC.; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS, INC.
Reel/Frame 036089/0633 →
SECURITY AGREEMENT Recorded Jun 19, 2015
From: JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 035936/0200 →
SECURITY INTEREST Recorded Aug 6, 2012
From: EUSA PHARMA (USA), INC.; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMAEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 028724/0604 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2012
From: ORPHAN MEDICAL, INC., A MINNESOTA CORPORATION
To: ORPHAN MEDICAL, INC., A DELAWARE CORPORATION
Reel/Frame 028567/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2012
From: ORPHAN MEDICAL, INC.
To: ORPHAN MEDICAL, LLC
Reel/Frame 028567/0708 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2012
From: ORPHAN MEDICAL, LLC
To: JPI COMMERCIAL, LLC
Reel/Frame 028567/0954 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2012
From: JPI COMMERCIAL, LLC
To: JAZZ PHARMACEUTICALS, INC.
Reel/Frame 028568/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2012
From: COOK, HARRY; HAMILTON, MARTHA; DANIELSON, DOUGLAS; GODERSTAD, COLETTE; REARDAN, DAYTON
To: ORPHAN MEDICAL, INC.
Reel/Frame 028567/0317 →